Boehringer Ingelheim

BOEHRINGER INGELHEIM NEWSROOM (2 press releases)

Advanced Filtering & Sorting Options:

Committee for Medicinal Products for Veterinary Use (CVMP) Meeting of 11-13 December 2012

PRESS RELEASE -- 14, December 2012

CVMP opinions on veterinary medicinal products  14-12-2012 — /europawire.eu/ — The Committee adopted by consensus a positive opinion for an initial marketing authorisation application for: Semintra (telmisartan), from Boehringer Ingelheim Vetmedica GmbH, for chronic kidney disease in cats. The Committee adopted … Read the full press release

Diabetes drug may reduce brain damage after stroke

PRESS RELEASE -- 5, December 2012

5-12-2012 — /europawire.eu/ — In a study in mice, scientists at Karolinska Institutet in Sweden have discovered a new potential therapy that may reduce brain damage following stroke in type 2 diabetic patients. The suggested drug is already approved for the … Read the full press release